Stay updated on Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial

Sign up to get notified when there's something new on the Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Version v3.6.6 was added to the study record history, and the previous v3.6.5 entry was removed from the log. This updates the version history to reflect the latest revision of the study record.
    Difference
    0.1%
    Check dated 2026-08-31T17:18:58.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The history page now shows Revision: v3.6.5 instead of v3.6.4, indicating a new interface release; this is a system-level update with no changes to the study data.
    Difference
    0.1%
    Check dated 2026-08-10T00:53:08.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The record history now reflects a new site revision, v3.6.4, replacing the previous v3.6.3.
    Difference
    0.1%
    Check dated 2026-07-26T18:51:25.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    A new revision entry v3.6.3 was added to the study record history, and the previous revision v3.6.2 was removed from the current history.
    Difference
    0.1%
    Check dated 2026-07-05T04:34:38.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    An updated revision (v3.6.2) appears in the record history. The previous revision (v3.6.0) is removed from the history, reflecting a new version entry for the page.
    Difference
    0.1%
    Check dated 2026-06-27T23:27:17.000Z thumbnail image
  9. Check
    93 days ago
    Change Detected
    Summary
    A new revision (v3.6.0) was added, including the recruitment status note 'No longer looking for participants', indicating the study is not enrolling. The older revision identifier (v3.5.5) was removed from the history.
    Difference
    0.6%
    Check dated 2026-06-13T16:48:52.000Z thumbnail image

Stay in the know with updates to Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial page.